CBmed Celebrates 10 Years!
Graz, Austria – September 23, 2024 – CBmed proudly marked its 10th anniversary, celebrating a decade of transformative advancements in precision medicine and biomarker research. Since its establishment in 2014, CBmed has become a trailblazer in personalized healthcare, leveraging cutting-edge science to improve patient outcomes worldwide.
A Decade of Innovation and Collaboration
From its humble beginnings, CBmed has emerged as a leader in translational medicine, specializing in identifying and validating biomarkers that enable tailored treatments for diseases like cancer. Its success stems from robust collaborations with top-tier partners, including pharmaceutical giant Boehringer Ingelheim, and prestigious academic institutions such as the Medical Universities of Graz and Vienna.
CBmed’s ability to bridge the gap between academic research and clinical application has positioned it as a key player in the biomedical industry. “Our journey has been defined by innovation, collaboration, and a commitment to improving lives through personalized medicine,” said Robert Lobnig, CEO / CFO during the celebration.
CBmed Celebrates 10 Years!
Graz, Austria – September 23, 2024 – CBmed proudly marked its 10th anniversary, celebrating a decade of transformative advancements in precision medicine and biomarker research. Since its establishment in 2014, CBmed has become a trailblazer in personalized healthcare, leveraging cutting-edge science to improve patient outcomes worldwide.
A Decade of Innovation and Collaboration
From its humble beginnings, CBmed has emerged as a leader in translational medicine, specializing in identifying and validating biomarkers that enable tailored treatments for diseases like cancer. Its success stems from robust collaborations with top-tier partners, including pharmaceutical giant Boehringer Ingelheim, and prestigious academic institutions such as the Medical Universities of Graz and Vienna.
CBmed’s ability to bridge the gap between academic research and clinical application has positioned it as a key player in the biomedical industry. “Our journey has been defined by innovation, collaboration, and a commitment to improving lives through personalized medicine,” said Robert Lobnig, CEO / CFO during the celebration.
A Celebration of Success
CBmed’s 10th-anniversary event brought together partners, shareholders, government representatives, and its dedicated team. The celebration highlighted the organization’s accomplishments and set the stage for an ambitious future.
“This milestone is a testament to our team’s dedication, our partners’ trust, and the support of all who believe in our mission,” said Robert Lobnig. “We’re excited for what’s ahead as we continue pushing boundaries and making a lasting impact on healthcare.”
CBmed is poised to lead the next era of precision medicine, turning scientific innovations into real-world solutions that benefit patients globally.
Here’s to the next decade of excellence in transforming healthcare!
